Innovations in ventricular tachycardia ablation

被引:0
作者
Qussay Marashly
Salim N. Najjar
Joshua Hahn
Graham J. Rector
Muzamil Khawaja
Mihail G. Chelu
机构
[1] Division of Cardiology,
[2] Department of Medicine,undefined
[3] Montefiore Medical Center,undefined
[4] Albert Einstein College of Medicine,undefined
[5] Division of Cardiology,undefined
[6] Baylor College of Medicine,undefined
[7] Baylor St. Luke’s Medical Center,undefined
[8] Texas Heart Institute,undefined
来源
Journal of Interventional Cardiac Electrophysiology | 2023年 / 66卷
关键词
Ventricular tachycardia; Ventricular arrhythmia; Catheter ablation; VT mapping; Stereotactic radiation therapy; Innovation;
D O I
暂无
中图分类号
学科分类号
摘要
Catheter ablation of ventricular arrhythmias (VAs) has evolved significantly over the past decade and is currently a well-established therapeutic option. Technological advances and improved understanding of VA mechanisms have led to tremendous innovations in VA ablation. The purpose of this review article is to provide an overview of current innovations in VA ablation. Mapping techniques, such as ultra-high density mapping, isochronal late activation mapping, and ripple mapping, have provided improved arrhythmogenic substrate delineation and potential procedural success while limiting duration of ablation procedure and potential hemodynamic compromise. Besides, more advanced mapping and ablation techniques such as epicardial and intramyocardial ablation approaches have allowed operators to more precisely target arrhythmogenic substrate. Moreover, advances in alternate energy sources, such as electroporation, as well as stereotactic radiation therapy have been proposed to be effective and safe. New catheters, such as the lattice and the saline-enhanced radiofrequency catheters, have been designed to provide deeper and more durable tissue ablation lesions compared to conventional catheters. Contact force optimization and baseline impedance modulation are important tools to optimize VT radiofrequency ablation and improve procedural success. Furthermore, advances in cardiac imaging, specifically cardiac MRI, have great potential in identifying arrhythmogenic substrate and evaluating ablation success. Overall, VA ablation has undergone significant advances over the past years. Innovations in VA mapping techniques, alternate energy source, new catheters, and utilization of cardiac imaging have great potential to improve overall procedural safety, hemodynamic stability, and procedural success.
引用
收藏
页码:1499 / 1518
页数:19
相关论文
共 632 条
[1]  
Cronin EM(2019)HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias Heart Rhythm 17 e2-e154
[2]  
Bogun FM(2020)Preventive or Deferred Ablation of Ventricular Tachycardia in Patients with Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT): a multicenter randomized trial Circulation 141 1057-1067
[3]  
Maury P(2007)Prophylactic catheter ablation for the prevention of defibrillator therapy N Engl J Med 357 2657-2665
[4]  
Peichl P(2016)Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs N Engl J Med 375 111-121
[5]  
Chen M(2012)Effects of electrode size and spacing on the resolution of intracardiac electrograms Coron Artery Dis 23 126-132
[6]  
Namboodiri N(2009)Cardiac ripple mapping: a novel three-dimensional visualization method for use with electroanatomic mapping of cardiac arrhythmias Heart Rhythm 6 1754-1762
[7]  
Willems S(2015)Application of ripple mapping to visualize slow conduction channels within the infarct-related left ventricular scar Circ Arrhythm Electrophysiol 8 76-86
[8]  
Tilz RR(2019)Identification of an epicardial slow conduction channel using ripple mapping in ablation of postinfarct ventricular tachycardia J Cardiovasc Electrophysiol 30 1156-1158
[9]  
Steven D(2015)Relationship between sinus rhythm late activation zones and critical sites for scar-related ventricular tachycardia: systematic analysis of isochronal late activation mapping Circ Arrhythm Electrophysiol 8 390-399
[10]  
Kääb S(2000)Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy Circulation 101 1288-1296